A Study of the Immunogenicity and Safety of SCTV01C in Population Aged ≥12 Years and Previously Vaccinated With Inactivated COVID-19 Vaccine
Stopped There was not a need to carry out a study in LAO any more.
Conditions
- COVID-19
- SARS-CoV2 Infection
Interventions
- BIOLOGICAL: SCTV01C
- BIOLOGICAL: Comirnaty
Sponsor
Sinocelltech Ltd.